Ran Geng

AppDirect, Inc. develops end-to-end commerce platform for selling, distributing, and managing cloud-based products and services. It offers AppMarket, AppReseller, AppBilling, and AppDistribution. The company was founded by Nicolas Desmarais, Andy Sen, and Daniel H. Saks in 2009 and is headquartered in San Francisco, CA.

Helion Energy, Inc. manufactures power generation technology. It develops power plants that would produce electricity by running a nuclear-fusion reaction whereby atoms merge at extremely high temperatures. The company was founded by David Kirtley, John Slough, Chris Pihl and George Votroubek in 2009 and is headquartered in Redmond, WA.

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Corvium, Inc. engages in the development of fist synthetic biology-based bacterial monitoring platform. Its product include Control-Pro, an EMP automation software that converts data into action. The company was founded by Bob Langer, Timothy Lu, Michael Koeris, Brett Chevalier, Micah Rosenbloom, Tanguy Chau, and James J. Collins in March 2009 and is headquartered in Woburnc, MA.

Formation8 Partners LLC (Formation8) is a venture capital firm founded in 2011 by Joe Lonsdale, Brian Koo, and Jim Kim. The firm is headquartered in San Francisco, California.

Mithril Capital Management LLC (Mithril Capital) is a venture capital firm founded in 2012 by Peter Andreas Thiel and Ajay Royan. The firm is headquartered in Austin, Texas.

Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA.

Eligo Bioscience SA operates a micobiome engineering laboratory. The company uses synthetic biology and CRISPR and CAS technology to develop highly precise antimicrobials. The firm?s sequence-specific antimicrobials can therefore discriminate between close bacterial strains and selectively eradicate harmful bacteria from the microbiome while sparing the beneficial ones. The company was founded by Timothy Lu, Luciano Marraffini, David Bikard and Xavier Duportet in May 2014 and is headquartered in Paris, France.

Quantify Labs, Inc. provides a content and analytics platform and builds software for institutional trading desks. Its solutions include desk analyst, sales, management, research and trading. The firm specializes in institutional finance, technology, capital markets, sell side, buy side and SaaS. The company was founded by Blair Livingston in 2012 and is headquartered in Toronto, Canada.

Eight Enterprises LLC (8VC) is a private equity/venture capital firm founded in 2015 by Joseph T. Lonsdale. The firm is headquartered in San Francisco, California.

Bioverge Funds Management LLC (Bioverge Funds Management) is a venture capital subsidiary of Bioverge, Inc. founded in 2016 by Neil Jay Littman and Rick Gibb. The firm is headquartered in San Francisco, CA.

Orca Biosystems, Inc. engages in empowering cell therapies by precisely engineering bone marrow transplants (BMT) using rapid clinical cell sorting of human grafts. The company was founded by Nathaniel fernhoff and Ivan K. Dimov and is headquartered in Mountain View, CA.

Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA.

BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel.

Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore.

Nest.Bio Ventures (Nest.Bio) is a venture capital firm founded in 2017. The firm is headquartered in Cambridge, Massachusetts.

Inversago Pharma, Inc. develops novel gastrointestinal drugs. The company was founded by Fran?ois Ravenelle in and is headquartered in Montreal, Canada.

RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA.

Dren Bio, Inc. operates as a biotechnology company. It focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents. The company was founded by John Wesley and Nenad Tomasevic in 2019 and is headquartered in San Carlos, CA.

Pango, Inc. develops privacy and security products. It offers hotspot shield, 1password, robo shield, and identity guard. The company was founded by Sujay Jaswa in 2018 and is headquartered in Redwood City, CA.

Kriya Therapeutics, Inc. designs and develops transformative new treatments for prevalent and severe chronic diseases. The company was founded by Shankar Ramaswamy and Roger Jeffs and is headquartered in Redwood City, CA.

Provectus Algae Pty Ltd. operates as a biotech company specialising in the optimisation of Algae to produce high-value compounds for a broad range of industries and applications. It offers natural and biosynthetic production services in antibiotics, vaccines, enzymes, cosmetics, hormones, terpenes, cannabinoids products.. The company was founded by Nusqe Spanton in 2018 and is headquartered in Noosaville, Australia.

Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018.

Part of CMC Consulting Boston, Inc., Artisan Healthcare Consulting, Inc. is a management consulting firm that provides strategic insights to healthcare product companies. The company is based in Waltham, MA. Artisan Healthcare Consulting provides strategic and analytic advice to a wide range of healthcare product companies. The company works across the biopharma industry to help clients steer emerging therapies through clinical development, launch them successfully, and drive success throughout the life cycle of their products. The company was founded in 2009 by Bob Delise, who has been the CEO since then. Artisan Healthcare Consulting was acquired by CMC Consulting Boston, Inc. on September 06, 2022.

Gandeeva Therapeutics, Inc. is a Canadian company that specializes in drug discovery using a unique approach to develop precision medicines. The company is based in Vancouver, Canada and was founded by Sriram Subramaniam, who has been the CEO since incorporation. The company's focus is on understanding the language by which proteins communicate in vivo, which is fundamental to deciphering biology. The company's discovery process involves identifying the optimal protein-protein interactions and altering protein structures to develop drugs that can treat various diseases.

Capstan Therapeutics, Inc. is a biotechnology company based in San Diego, CA. Capstan Therapeutics aims to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. The company's platform technology, TLNPs, is designed to deliver payloads and gene editing tools to reprogram specific cell types in vivo. This technology has the potential to generate transformative therapies for various disease areas, including autoimmune disorders, oncology, fibrosis, and monogenic blood disorders. Capstan Therapeutics, Inc. was founded in 2022 by Haig Aghajanian. Laura K. Shawver has been the CEO of the company since 2022.